JPM Raises Recession Odds, Lilly Blows Past E...

Cramer explains why he’s ‘ready to get rid of’ this industrial technology stock. Become an Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks every day as they talk candidly about the market’s biggest headlines, analyst calls and holdings in the Charitab ...  Show more

Ariel Investments Co-CEO John Rogers joins to discuss the impact of Warren Buffett stepping down from his chairman role at Berkshire Hathaway. Then, we break down expectations for the iPhone 18 which hits the stores today. Plus, Dr. Vin Gupta shares the pros and cons of using AI ...  Show more

Earnings season is in full swing, with Apple and Amazon headlining the action. Deepwater Asset Management’s Gene Munster joins to break down the key takeaways from the day’s big reports. And Eli Lilly dropping as the drugmaker cuts its profit forecast. Mizuho’s Jared Holz digs ...

Shares of Eli Lilly taking a hit, as the pharma giant cuts its sales outlook. But could the dip be a buying opportunity? The latest out of JP Morgan’s Health Care Conference in San Francisco. And speaking of JP Morgan… the big bank and its peers kicking off earnings season tom ...

The averages ended the session mixed and Jim Cramer is breaking down how the news of the day moved the major indexes. First, Cramer's tackling the tech-nicals and going Off The Charts on the QQQ to see where tech is headed after leading the market higher this year. Then, Crame ...

The Dow was down 942 points at its session lows in a September-style selloff to start the week and Jim Cramer is helping investors navigate the day’s volatility. Then, as pharmaceutical companies focus on COVID-19, Eli Lilly CEO Dave Ricks checks in to discuss the company's pr ...